This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Effepharm (Shanghai) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Liulei Chang: Innovator in Pharmaceutical Ingredients
Introduction
Liulei Chang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical ingredients through his innovative research and development. His work focuses on enhancing the properties of compounds used in various health-related applications.
Latest Patents
Liulei Chang holds a patent for a "Polymorphic form of reduced beta-nicotinamide mononucleotide disodium salt, and preparation method therefor and use thereof." This patent describes a polymorph of a reduced β-nicotinamide mononucleotide disodium salt, along with its preparation method and potential uses. The polymorph exhibits excellent solubility, stability, flow performance, and resistance to hygroscopicity. Furthermore, its purification effects surpass those of amorphous forms, making it a valuable ingredient in pharmaceuticals, healthcare products, cosmetics, and food additives.
Career Highlights
Liulei Chang is associated with Effepharm (Shanghai) Co., Ltd., where he continues to push the boundaries of innovation in the pharmaceutical industry. His dedication to research and development has positioned him as a key player in the field.
Collaborations
Liulei Chang collaborates with talented individuals such as Xing Gao and Jianjun Yu. Their combined expertise fosters a creative environment that drives innovation and enhances the quality of their projects.
Conclusion
Liulei Chang's contributions to the field of pharmaceutical ingredients through his patented innovations demonstrate his commitment to advancing health-related applications. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile